HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative studies on immunological properties of antitumor polysaccharide TC-13.

Abstract
The biological and immunological characteristics of TC-13, an antitumor protein-bound polysaccharide, were studied. TC-13 had no direct cytocidal effect on Ehrlich carcinoma, but it induced antitumor resistance in mice whose tumors were regressed by TC-13. TC-13 changed the electrophoretic pattern of serum proteins of mice after its ip administration, causing a slow increase of the LB component and a rapid increase of the X component. TC-13 augmented the delayed-type hypersensitivity reaction to tumor homogenate, anti-SRBC antibody formation and the cytocidal activity of macrophages in an antibody-dependent system, but it had little or no effect on blast formation of spleen lymphocytes or carbon clearance. These results and comparative studies with other immunomodulators suggest that TC-13 is a unique polysaccharide having properties intermediate between those of lentinan, a simple-structured homologous polysaccharide from basidiomycetes, and lipopolysaccharide, a cell-surface component from bacteria.
AuthorsM Kohno, S Abe, H Nakajima, M Yamazaki, D Mizuno
JournalGan (Gan) Vol. 73 Issue 4 Pg. 618-26 (Aug 1982) ISSN: 0016-450X [Print] Japan
PMID6759288 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Glycopeptides
  • Glycoproteins
  • Polysaccharides, Bacterial
  • TC 13
Topics
  • Animals
  • Anti-Bacterial Agents
  • Antibody-Dependent Cell Cytotoxicity (drug effects)
  • Antineoplastic Agents (immunology)
  • Blood Protein Electrophoresis
  • Carcinoma, Ehrlich Tumor (immunology)
  • Cells, Cultured
  • Glycopeptides
  • Glycoproteins (immunology, pharmacology)
  • Hemolytic Plaque Technique
  • Hypersensitivity, Delayed (immunology)
  • Lymphocyte Activation (drug effects)
  • Macrophages (immunology)
  • Male
  • Mice
  • Polysaccharides, Bacterial (immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: